Picture of Redsense Medical AB (publ) logo

REDS — Redsense Medical AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Sweden's Redsense returns to profit in Q2 on higher sensor patch sales

Sweden's Redsense returns to profit in Q2 on higher sensor patch sales


Overview

  • Sweden blood leakage monitor maker's Q2 net sales rose yr/yr, returning to profit

  • Company attributes improved results to stronger operational base and higher sensor patch sales

  • Company launched new digital training platform to support broader adoption


Outlook

  • Company aims to increase usage with existing U.S. providers and reach more clinics

  • Company focuses on expanding Redsense Clamp opportunities in UK and Germany

  • Company says it will maintain financial and operational discipline while pursuing growth


Result Drivers

  • HIGHER SENSOR PATCH SALES - Co said increased sensor patch sales indicate more active use of installed base

  • RESTRUCTURING AND EFFICIENCY - Co attributed improved operating performance to restructuring and efficiency work completed in 2025

  • DIGITAL TRAINING PLATFORM - Co launched new digital training portal to support broader adoption and address training challenges


Company press release: ID:nWkr7yvvTX


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Sales

SEK 7.09 mln

Q2 EPS

SEK 0.03

Q2 Net Income

SEK 421,000

Q2 EBIT

SEK 377,000


Reuters Recommended Reads

  • Aug 18 - Sweden's OssDsign Q2 sales rise 2.4% gross margin falls

  • Aug 19 - Sweden's SciBase H1 revenue rises

  • Aug 18 - Coloplast expects Kerecis wound-care unit to return to growth in 2027, CFO says


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Redsense Medical AB (publ)

See all news